|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng H, Ren W, Pan X, Zhang Q, Liu B, Liu
S, He J and Zhou Z: Role of intravoxel incoherent motion MRI in
early assessment of the response of esophageal squamous cell
carcinoma to chemo-radiotherapy: A pilot study. J Magn Reson
Imaging. 48:349–358. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smyth EC, Lagergren J, Fitzgerald RC,
Lordick F, Shah MA, Lagergren P and Cunningham D: Oesophageal
cancer. Nat Rev Dis Primers. 3:170482017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burki TK: Definitions of oesophageal
cancer. Lancet Oncol. 18:e712017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakajima M and Kato H: Treatment options
for esophageal squamous cell carcinoma. Expert Opin Pharmacother.
14:1345–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clark MB, Johnston RL, Inostroza-Ponta M,
Fox AH, Fortini E, Moscato P, Dinger ME and Mattick JS: Genome-wide
analysis of long noncoding RNA stability. Genome Res. 22:885–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tani H, Mizutani R, Salam KA, Tano K,
Ijiri K, Ai W, Isogai T, Suzuki Y and Akimitsu N: Genome-wide
determination of RNA stability reveals hundreds of short-lived
noncoding transcripts in mammals. Genome Res. 22:947–956. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:39652017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hon CC, Ramilowski JA, Harshbarger J,
Bertin N, Rackham OJ, Gough J, Denisenko E, Schmeier S, Poulsen TM,
Severin J, et al: An atlas of human long non-coding RNAs with
accurate 5′ ends. Nature. 543:199–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rao AKDM, Rajkumar T and Mani S:
Perspectives of long non-coding RNAs in cancer. Mol Biol Rep.
44:203–218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin CY and Xu HM: Novel perspectives of
long non-coding RNAs in esophageal carcinoma. Carcinogenesis.
36:1255–1262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Xie H, Gao Q, Zhan H, Xiao H, Zou
Y, Zhang F, Liu Y and Li J: Colon cancer associated transcripts in
human cancers. Biomed Pharmacother. 94:531–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xin Y, Li Z, Zheng H, Chan MTV, Ka Kei and
Wu W: CCAT2: A novel oncogenic long non-coding RNA in human
cancers. Cell Prolif. 50:2017. View Article : Google Scholar
|
|
16
|
Zhang X, Xu Y, He C, Guo X, Zhang J, He C,
Zhang L, Kong M, Chen B and Zhu C: Elevated expression of CCAT2 is
associated with poor prognosis in esophageal squamous cell
carcinoma. J Surg Oncol. 111:834–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q,
Yin R and Xu L: Long noncoding RNA CCAT2 correlates with smoking in
esophageal squamous cell carcinoma. Tumour Biol. 36:5523–5528.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Nangia-Makker P, Farhana L and
Majumdar APN: A novel mechanism of lncRNA and miRNA interaction:
CCAT2 regulates miR-145 expression by suppressing its maturation
process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang P, Yang Y, An W, Xu J, Zhang G, Jie J
and Zhang Q: The long noncoding RNA-ROR promotes the resistance of
radiotherapy for human colorectal cancer cells by targeting the
p53/miR-145 pathway. J Gastroenterol Hepatol. 32:8372017.
View Article : Google Scholar
|
|
20
|
Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li
D, Lai L and Jiang BH: MiR-145 directly targets p70S6K1 in cancer
cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res.
40:761–774. 2012. View Article : Google Scholar :
|
|
21
|
Tao J, Zhang J, Ling Y, McCall CE and Liu
TF: Mitochondrial sirtuin 4 resolves immune tolerance in monocytes
by rebalancing glycolysis and glucose oxidation homeostasis. Front
Immunol. 9:4192018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Kusaba H and Saijo N: A summary report of
response evaluation criteria in solid tumors (RECIST criteria). Gan
To Kagaku Ryoho. 27:1–5. 2000.In Japanese. PubMed/NCBI
|
|
24
|
Wu L, Jin L, Zhang W and Zhang L: Roles of
long non-coding RNA CCAT2 in cervical cancer cell growth and
apoptosis. Med Sci Monit. 22:875–879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou N, Si Z, Li T, Chen G, Zhang Z and Qi
H: Long non-coding RNA CCAT2 functions as an oncogene in
hepatocellular carcinoma, regulating cellular proliferation,
migration and apoptosis. Oncol Lett. 12:132–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Campbell NP and Villaflor VM: Neoadjuvant
treatment of esophageal cancer. World J Gastroenterol.
16:3793–3803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lordick F, Hölscher AH, Haustermans K and
Wittekind C: Multimodal treatment of esophageal cancer. Langenbecks
Arch Surg. 398:177–187. 2013. View Article : Google Scholar
|
|
28
|
Sihvo E, Anttonen A and Huuhtanen R:
Treatment of esophageal cancer. Duodecim. 130:565–572. 2014.In
Finnish.
|
|
29
|
Leszczynska KB, Foskolou IP, Abraham AG,
Anbalagan S, Tellier C, Haider S, Span PN, O'Neill EE, Buffa FM and
Hammond EM: Hypoxia-induced p53 modulates both apoptosis and
radiosensitivity via AKT. J Clin Invest. 125:2385–2398. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Olive PL and Durand RE: Apoptosis: An
indicator of radiosensitivity in vitro? Int J Radiat Biol.
71:695–707. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye C, Sun NX, Ma Y, Zhao Q, Zhang Q, Xu C,
Wang SB, Sun SH, Wang F and Li W: MicroRNA-145 contributes to
enhancing radiosensitivity of cervical cancer cells. FEBS Lett.
589:702–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong P, Zhang T, He D and Hsieh JT:
MicroRNA-145 modulates tumor sensitivity to radiation in prostate
cancer. Radiat Res. 184:630–638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K,
Wang T, Feng B, Chen Y, Song H, Wang R and Chu X: Long non-coding
RNA ROR promotes radioresistance in hepatocelluar carcinoma cells
by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
Arch Biochem Biophys. 645:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao P, Meng Q, Liu LZ, You YP, Liu N and
Jiang BH: Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
Biochem Biophys Res Commun. 395:219–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chai X, Sun D, Han Q, Yi L, Wu Y and Liu
X: Hypoxia induces pulmonary arterial fibroblast proliferation,
migration, differentiation and vascular remodeling via the
PI3K/Akt/p70S6K signaling pathway. Int J Mol Med. 41:2461–2472.
2018.PubMed/NCBI
|
|
36
|
Weichselbaum RR, Liang H, Deng L and Fu
YX: Radiotherapy and immunotherapy: A beneficial liaison? Nat Rev
Clin Oncol. 14:365–379. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Krause M, Dubrovska A, Linge A and Baumann
M: Cancer stem cells: Radioresistance, prediction of radiotherapy
outcome and specific targets for combined treatments. Adv Drug
Deliv Rev. 109:63–73. 2017. View Article : Google Scholar
|
|
38
|
Ma J, Li Y, Wu M and Li X: Oxidative
stress-mediated p53/p21WAF1/CIP1 pathway may be involved
in microcystin-LR-induced cytotoxicity in HepG2 cells. Chemosphere.
194:773–783. 2018. View Article : Google Scholar
|
|
39
|
Ma J, Chen X, Xin G and Li X: Chronic
exposure to the ionic liquid [C8mim]Br induces
inflammation in silver carp spleen: Involvement of oxidative
stress-mediated p38MAPK/NF-κB signalling and microRNAs. Fish
Shellfish Immunol. 84:627–638. 2019. View Article : Google Scholar
|
|
40
|
Kim EM, Jung CH, Kim J, Hwang SG, Park J
and Um HD: The p53/p21 complex regulates cancer cell invasion and
apoptosis by targeting Bcl-2 family proteins. Cancer Res.
77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hernandez Borrero LJ, Sikder R, Lulla A,
Gokare P, Del Valle PR, Tian X, Zhang S, Abbosh PH and El-Deiry WS:
Bcl-2 protein targeting by the p53/p21 complex-letter. Cancer Res.
78:2770–2771. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Yu H, Cai H and Wang Y: Expression
of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric
cancer: Correlation with clinicopathologic characteristics and
survival. J Surg Oncol. 109:859–864. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hermeking H, Funk JO, Reichert M, Ellwart
JW and Eick D: Abrogation of p53-induced cell cycle arrest by
c-Myc: Evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene.
11:1409–1415. 1995.PubMed/NCBI
|
